Bonesupport Q2 operating income climbs 63% to SEK 89.6 million; net sales increase 25% to SEK 355.7 million

• Bonesupport net sales rose 25% in Q2 to SEK 355.7 million, while operating result climbed to SEK 89.6 million.
• Gross margin slipped 1.5 percentage points to 90.8%; EPS after dilution increased to SEK 1.23.
• First-half net sales increased 20% to SEK 679.7 million, while operating result rose to SEK 161.7 million.
• CMS proposed FY2027 IPPS rule changes that improve payments for CERAMENT G in complex orthopedic infections; final ruling expected late summer.
• Guidance narrowed to 33%-36% net sales growth in constant exchange rates for 2026, from more than 35% previously.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bonesupport Holding AB published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.